Lake Street analyst Thomas Flaten maintained a Buy rating on Evaxion Biotech (EVAX – Research Report) today and set a price target of $6.00.

Oncolytics (ONCY) announced that it received a delinquency notification letter from Nasdaq indicating that the company is not currently in ...

Products from Japan's Prossence to Korea's Sulwhasoo, Innisfree and Laneige, have had a big impact on global skincare habits, ...

Embree Financial Group lessened its stake in shares of Amazon.com, Inc. (NASDAQ:AMZN) by 2.5% in the fourth quarter, Holdings Channel reports. The institutional investor owned 30,561 shares of the ...

The Janus Henderson Global Sustainable Equity Fund returned -5.88% for Q4 2024. Click here to read the full commentary.

The Janus Henderson Global Sustainable Equity Managed Account Portfolio returned -5.71% (gross) for Q4 2024. Click here to ...

An Indian astronaut - or a Gaganyatri - will soon travel to the International Space Station (ISS), and a groundbreaking India ...